Aquifer Hypertension Guidelines Module
|
|
- Gilbert Ward
- 5 years ago
- Views:
Transcription
1 Aquifer Hypertension Guidelines Module 2018 Aquifer Hypertension Guidelines Module 1
2 1. Introduction. In 2013 the National Heart Lung and Blood Institute (NHLBI) asked the American College of Cardiology (ACC) and the American Heart Association (AHA) to assume responsibility for producing national guidelines regarding cardiovascular disease prevention, including the management of hypertension. In 2017, the first ACC/AHA hypertension guideline was published and immediately became the most comprehensive and up-to-date review of this crucial topic 1. The guideline document makes a large number of specific recommendations on a broad range of topics, many of which are beyond the scope of this summary. Below is a summary of the key recommendations affecting day-to-day practice Aquifer Hypertension Guidelines Module 2
3 2. New Definition of Hypertension. There is ample evidence from observational studies that starting at systolic blood pressures (SBP) as low as 115 mmhg, each 10 mmhg increase in SBP leads to a consequent increase in the incidence of a wide range of negative outcomes, including acute coronary syndrome, chronic kidney disease, cerebrovascular disease, heart failure and all-cause mortality. 2 This relationship is log-linear, so the rate of the increase in bad outcomes gets increasingly high as SBP goes up. Due to this evidence, and to clinical trial research about the impact of interventions to push blood pressures lower than the traditional goal of 140/90 mmhg, the new guideline encourages physicians to change the classification of adult blood pressures as follows. BP Category SBP DBP Normal < 120 mmhg and < 80 mmhg Elevated mmhg and < 80 mmhg Hypertension Stage mmhg or mmhg Stage mmhg or 90 mmhg This recommendation represents a major change in clinical thinking as it lowers the decadeslong definition of hypertension from pressures above 140/90 mmhg to those above 130/80 mmhg. One estimate of the impact of this new definition is that 45.6% of the US adult population will now meet the criteria for a diagnosis of hypertension Aquifer Hypertension Guidelines Module 3
4 3. Use of Out-of-Office Blood Pressures. It has long been known that many patients experience higher blood pressure readings in the physician s office than at home. Particularly with the new lower definition of hypertension, the phenomenon of white coat hypertension could lead to the incorrect labeling of healthy adults as having hypertension. Related to this is that blood pressure readings in clinical trials are typically as much as 5-10 mmhg lower than those in physician offices, due to the proper measurement of blood pressure after a five-minute sitting period in research studies (something very difficult to achieve in a busy medical practice). 4 Teaching Point: Out-of-office blood pressure measurement for hypertension The new guideline encourages physicians to confirm the diagnosis of hypertension and to titrate medication therapy through the use of out-of-office blood pressure readings. This can be achieved via either: Ambulatory Blood Pressure Monitoring (ABPM) - formal 24-hour blood pressure measurements using a provider-provided device, or Home Blood Pressure Monitoring (HBPM) - blood pressure readings taken by a patient at home. The meta-analysis conducted for the 2017 guideline found that clinical trials of self-measured blood pressure led to a significant, but transient (six-month) improvement in SBP compared to patients having office-based blood pressure measurements. 5 While ABPM and HBPM are increasing in frequency, many existing practices do not have well-developed systems in place to implement this particular recommendation Aquifer Hypertension Guidelines Module 4
5 4. When to Initiate BP-Lowering Medications. There are a large number of lifestyle measures that have been demonstrated to lower blood pressure and decrease cardiovascular outcomes. As such, the 2017 guidelines highlight behavioral measures as the first line for managing elevated blood pressure (SBP mmhg) and hypertension (whether initiating medications or not). Teaching Point: Recommended behavioral interventions for elevated blood pressure Weight loss for those who are overweight or obese. A heart healthy diet, such as the DASH diet or Mediterranean diet. Sodium restriction, or in those over 75 who are well nourished a trial of sodium restriction (sodium restriction may lead to decreased oral intake in older patients). Potassium supplementation, particularly from diet (eg. tomatoes, avocados, green leafy vegetables, et al.) Increased physical activity through a structured exercise program. Restriction of alcohol consumption to no more than 2 standard drinks per day for men or 1 standard drink per day for women and for all adults 65 years or older. Interventions that reduce the risk of an outcome have the largest impact when implemented in patients at higher baseline risk of that outcome (ie. larger absolute risk reduction, lower numberneeded-to-treat). Considering this phenomenon, the 2017 guidelines encourage physicians to calculate a patient s baseline risk when considering blood pressure lowering medications. Commensurate with other recent guidelines (see the Aquifer Cholesterol module), they recommend the use of the Pooled Cohort Equations to estimate a patient s 10-year risk of atherocsclerotic cardiovascular disease (ASCVD) as the principal means for assessing baseline risk Aquifer Hypertension Guidelines Module 5
6 Physicians are encouraged to consider starting medication therapy for blood pressure as follows: Patient Group 10-year ASCVD risk Behavioral Interventions Medications* Stage 1 Hypertension ( / mmhg) Stage 1 Hypertension ( / mmhg) Stage 2 Hypertension (>= 140/90 mmhg) < 10% Yes No 10% Yes Yes < OR 10% Yes Yes All patients with clinical ASCVD < OR 10% Yes Yes Patients with diabetes mellitus < OR 10% Yes Yes Patient with chronic kidney disease < OR 10% Yes Yes * For all groups, the target blood pressure is 130/80 mmhg Only consider medications for such patients with stage 1 or 2 hypertension (ie. BP >= 130/80) The current guidelines dramatically increase the percentage of US adults who meet the criteria for hypertension (see New Definition of Hypertension above). However, due to the risk-based strategy for starting medications, a published analysis estimates that there will be only 1.9% more patients who require medication therapy for blood pressure (compared to prior guidelines) on the basis of these current guidelines Aquifer Hypertension Guidelines Module 6
7 5. Choice of Medication Therapy for Hypertension. In general, the current guidelines were consistent with prior guidelines in finding that a variety of classes of blood pressure lowering medications are effective in preventing complications of hypertension. The choices of blood pressure agents are summarized in the following table: Group Medication Choices Notes General adult population Patients with Diabetes Thiazide Calcium Channel Blocker (CCB) ACE Inhibitor (ACE-I) Angiotensin Receptor Blocker (ARB) Thiazide CCB ACE-I ARB The meta-analysis conducted for the guidelines found a slight preference for thiazides (particularly chlorthalidone) as the first choice. In the absence of nephropathy, there is no preference for any starting agent. Patients with CKD ACE-I or ARB CCB and/or thiazide may be added as needed to achieve a goal of 130/80 mmhg An ACE-I or ARB is the first line in CKD. They should not be used in combination. Black Patients Thiazide CCB ACE-I ARB Older Adults Thiazide CCB ACE-I ARB Despite the meta-analysis not finding race-based differences in outcomes by choice of medication 5, this guideline recommends black patients be treated with either a thiazide or CCB as the first line. Thiazides are a reasonable first choice for most patients regardless of race. Older patients are more prone to adverse events with tight BP control, including orthostasis, falls, and kidney injury. Caution should be taken to ensure that older patients are not orthostatic before changes in medication therapy. Recommendations for tight BP control are restricted to community-dwelling seniors who are not nursing-home eligible. Patients with a limited life expectancy are unlikely to benefit from tight BP control Aquifer Hypertension Guidelines Module 7
8 6. Differences from other recent guidelines. The 2017 ACC/AHA hypertension guideline represents a departure from several prominent recent guidelines. The differences can be attributed in part to the influence of more recent blood pressure trials (most notably the SPRINT trial see below 6 ) on the new guideline, but also due to differing views of the large body of evidence, which is often difficult to combine into a cohesive whole and is occasionally contradictory. The table below summarizes some of the differences in two other recent blood pressure guidelines. Guideline Agency Differences from the 2017 ACC/AHA Guideline Comments 8th Joint National BP goal of 140/90 mmhg for most Committee (JNC8) 7 adults BP goal of 150/90 mmhg for adults 60 BP goal of 140/90 mmhg for patient with diabetes More clearly articulated race-based preferences for particular classes of medications 2017 ACP*/AAFP 8 Guideline restricted to adults 60 BP goal of 150/90 mmhg for low risk adults 60 BP goal of 140/90 mmhg for high risk adults 60 BP goal of 140/90 mmhg for adults 60 with history of stroke Predated the SPRINT Trial Took a very strict evidence-based approach Often criticized for its higher SBP goal for adults 60, because this group has higher baseline ASCVD risk Took SPRINT into consideration Took a very strict evidence-based approach Panelists expressed concern over evidence of adverse events in lowering the SBP goal below 120 mmhg in the SPRINT trial (eg. syncope) * American College of Physicians American Academy of Family Physicians SPRINT Trial 6 : The 2017 ACC/AHA guideline was heavily influenced by the results of the 2015 SPRINT trial. This randomized trial studied two blood pressure goals in patients 50 years and older who had increased risk for cardiovascular disease (known prior CVD, chronic kidney disease, 10-year ASCVD risk of 15% or higher, or age > 75) and who did NOT have diabetes. In this population, those randomized to a blood pressure goal of 120/90 mmhg suffered significantly fewer cardiovascular outcomes (and all-cause mortality) than those given a goal of 140/90 mmhg. The average age was ~68, so this study provides some evidence that lower blood pressure goals may be better in older non-diabetic patients with increased CVD risk. As a cautionary note, patients in the tight control arm experienced significantly more adverse events related to antihypertensives, including hypotension, syncope, electrolyte abnormalities, and acute kidney injury. Older patients are both more likely to benefit from the positive benefits of blood pressure lowering (due to their higher baseline CVD risk) and more likely to experience these adverse events Aquifer Hypertension Guidelines Module 8
9 7. Different Viewpoints In December of 2017, the American Academy of Family Physicians announced its decision to not endorse the new ACC/AHA hypertension guideline and to continue to endorse the JNC8 guideline published in In the explanation of this decision the authors cited several reasons: They argued that much of the new guideline was not based on a systematic review of the literature. While it is true that many of the >100 individual recommendations were not supported by a systematic review, a new systematic review was conducted about most of the major changes in blood pressure management in the new guideline (eg. new treatment goals and choice of medications). They point out that the published systematic review looking at the optimal blood pressure treatment goals did not look at harms in addition to benefits of lower treatment goals. This is an important and valid critique. They argue that the guideline was heavily influenced by the SPRINT trial (see above) and that other trials were minimized. In fact, the chair of the new guideline panel was the principal investigator from the SPRINT trial, a situation which could influence the guideline panel s thinking. In the meta-analysis conducted in the systematic review for this new guideline, the SPRINT trial was not given extra weighting over other trials. In addition, other, more recent meta-analyses have confirmed the findings of this systematic review. They argue that the use of the ASCVD risk tool as a guide for whom to target for medication therapy is not based on randomized trials. The AAFP s decision highlights the challenges to and subtleties of interpreting clinical evidence and translating it into practice. Aquifer encourages students to remember that clinical guidelines are not intended to be treated like rigid prescriptions. Physicians must individualize their clinical decisions to the particular needs of their actual patients, using guidelines as frameworks for improving the quality of care rather than as algorithms Aquifer Hypertension Guidelines Module 9
10 Contributors David Anthony, MD, MSc authored this 2018 version. Alexander Chessman, MD authored an earlier version and collaborated on this 2018 revision. Kathryn E. Callahan, MD collaborated on this 2018 version Aquifer Hypertension Guidelines Module 10
11 End Notes 1 Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. Published online November 13, Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.lancet Dec 14;360(9349): Muntner P, Carey RM, Gidding S, Jones DW, et al. Potential U.S. Population Impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. J Am Coll Cardiol Jan 16;71(2): Chobanian AV. Hypertension in What is the right target? JAMA February 14, 2017;317(6): Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, Miller ER 3rd, Polonsky T, Thompson-Paul AM, Vupputuri S. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. Published online November 13, The SPRINT Research Group. A Randomized trial of intensive versus standard blood-pressure control. NEJM 2015;373: James PA, Oparil S, Carter BL, Cushman WC, et al evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311(5): Qaseem A, Wilt TJ, Rich R, Humphrey LL, et al. Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2017;166(6): Accessed 12/20/ Aquifer Hypertension Guidelines Module 11
Hypertension and the 2017 Guidelines Meeting the Targets in Small Groups. Lisa Ivy APRN
Hypertension and the 2017 Guidelines Meeting the Targets in Small Groups Lisa Ivy APRN The 2017 Guideline is an Update to JNC7 New information regarding BP related risk of CVD Ambulatory BP monitoring
More informationUsing the New Hypertension Guidelines
Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in
More information2017 High Blood Pressure Clinical Practice Guideline
2017 High Blood Pressure Clinical Practice Guideline Applying the Latest Hypertension Guideline to Your Practice Carmine D Amico, D.O., F.A.C.C. 2017 ACC / AHA / AAPA / ABC / ACPM / AGS / APhA / ASH /
More informationNew Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets
New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets Sidney C. Smith, Jr. MD, FACC, FAHA Professor of Medicine/Cardiology University of
More informationEvolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH)
Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH) Sidney C. Smith, Jr. MD, FACC, FAHA, FESC Professor of Medicine/Cardiology University of North Carolina
More informationJNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults
JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation
More informationSummary, Scope, BP Classification, BP thresholds and Targets
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/ PCNA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults Summary, Scope, BP Classification, BP thresholds
More informationHypertension Guidelines: Lessons for Primary Care. Paul A James MD Professor and Chair Department of Family Medicine University of Washington
Hypertension Guidelines: Lessons for Primary Care Paul A James MD Professor and Chair Department of Family Medicine University of Washington Disclaimer and Financial Disclosure I have no financial interests
More informationHTN talk_l Davis_ /28/2018
1 2 GUIDELINES PUBLISHED AHEAD OF PRINT NOV 13, 2017 = SAME DAY AS PUBLIC PRESENTATION LESLIE L DAVIS, PHD, RN, ANP-BC, FPCNA, FAANP, FAHA The New Guidelines Have Been Published! Whelton PK, Carey RM,
More informationNew Hypertension Guideline Recommendations for Adults July 7, :45-9:30am
Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July
More informationLong-Term Care Updates
Long-Term Care Updates August 2015 By Darren Hein, PharmD Hypertension is a clinical condition in which the force of blood pushing on the arteries is higher than normal. This increases the risk for heart
More informationNone. Disclosure: Relationships with Industry Conflicts of Interests. Learning Objectives: Participants will be able to:
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) James W. Shaw, MD Memorial Lecture
More informationManaging Hypertension in 2018
MANAGING HYPERTENSION IN 2018 How Do We Work With Conflicting Data and Conflicting Guidelines? Disclosure No relevant financial relationships Robert B. Baron, MD MS Professor and Associate Dean UCSF School
More informationTHE IMPACT OF HYPERTENSION GUIDELINES. Daniel Lackland
THE IMPACT OF HYPERTENSION GUIDELINES Daniel Lackland Disclosures Member of NHLBI Risk Assessment Workgroup Member of 2014 Hypertension Guidelines (JNC 8) Member of Evidence Rating Committee for ACC/AHA
More informationHYPERTENSION: ARE WE GOING TOO LOW?
HYPERTENSION: ARE WE GOING TOO LOW? George L. Bakris, M.D.,F.A.S.N.,F.A.S.H., F.A.H.A. Professor of Medicine Director, ASH Comprehensive Hypertension Center University of Chicago Medicine Chicago, IL USA
More informationInt. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences
Research Article JNC 8 versus JNC 7 Understanding the Evidences Anns Clara Joseph, Karthik MS, Sivasakthi R, Venkatanarayanan R, Sam Johnson Udaya Chander J* RVS College of Pharmaceutical Sciences, Coimbatore,
More informationWhat s In the New Hypertension Guidelines?
American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the
More informationDISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.
JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES Tiffany Dickey, PharmD Assistant Professor, UAMS COP Clinical Pharmacy Specialist, Mercy Hospital Northwest AR DISCLOSURE I
More informationMODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk
MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu
More informationDisclosure. No relevant financial relationships. Placebo-Controlled Statin Trials
PREVENTING CARDIOVASCULAR DISEASE IN WOMEN: Current Guidelines for Hypertension, Lipids and Aspirin Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial
More informationManaging Hypertension in 2016
Managing Hypertension in 2016: Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu
More informationBlood Pressure LIMBO How Low To Go?
Blood Pressure LIMBO How Low To Go? Joseph L. Kummer, MD, FACC Bryan Heart Spring Conference April 21 st, 2018 Hypertension Epidemiology Over a billion people have hypertension Major cause of morbidity
More informationObjectives. Describe results and implications of recent landmark hypertension trials
Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships
More informationNew Hypertension Guidelines: Why the change? Neil Brummond, M.D. Avera Medical Group Internal Medicine Sioux Falls, SD
New Hypertension Guidelines: Why the change? Neil Brummond, M.D. Avera Medical Group Internal Medicine Sioux Falls, SD None Disclosures Objectives Understand trend in blood pressure clinical practice guidelines
More information4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?
HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL
More information2/11/2019 CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES DUALITY OF INTEREST
CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES George L. Bakris, M.D.,F.A.S.N., F.A.H.A. Professor of Medicine Director, Am Heart Assoc. Comprehensive Hypertension Center University of Chicago Medicine
More informationManagement of Lipid Disorders and Hypertension: Implications of the New Guidelines
Management of Lipid Disorders and Hypertension Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine
More informationClinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital
Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8 Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Objectives Review the Eighth Joint National Committee (JNC
More informationWhich antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017
Which antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017 The most important reason for treating hypertension in primary care is to prevent
More informationHypertension Update. Aaron J. Friedberg, MD
Hypertension Update Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Background Diagnosis Management Overview Guideline
More informationHypertension and Diabetes Should we be SPRINTING or Reaching an ACCORD?
Hypertension and Diabetes Should we be SPRINTING or Reaching an ACCORD? Suzanne Oparil, MD Distinguished Professor of Medicine, Professor of Cell, Developmental and Integrative Biology Director, Vascular
More information2. Measurement Specifications 3. Patient Messaging 4. Provider Messaging Other Recent Guidelines
Measure Up/Pressure Down Response to the Release of 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National
More informationPotential U.S. Population Impact of the 2017 American College of Cardiology/ American Heart Association High Blood Pressure Guideline
Accepted Manuscript Potential U.S. Population Impact of the 2017 American College of Cardiology/ American Heart Association High Blood Pressure Guideline Paul Muntner, PhD, Robert M. Carey, MD, Samuel
More informationTreating Hypertension in 2018: What Makes the Most Sense Today?
Treating Hypertension in 2018: What Makes the Most Sense Today? Daniel Blanchard, MD Professor of Medicine UC San Diego Cardiovascular Center La Jolla, California 1 2 Speaker Disclosures Consultant and/or
More informationIn late 2017, the American College of Cardiology (ACC)
SPECIAL ARTICLE The 2017 U.S. Hypertension Guidelines: What Is Important for Older Adults? William C. Cushman, MD,* and Karen C. Johnson, MD, MPH In late 2017, the American College of Cardiology (ACC)
More informationThe New Hypertension Guidelines
The New Hypertension Guidelines Joseph Saseen, PharmD Professor and Vice Chair, Department of Clinical Pharmacy University of Colorado Anschutz Medical Campus Disclosure Joseph Saseen reports no conflicts
More informationDon t let the pressure get to you:
Balanced information for better care Don t let the pressure get to you: An update on the changing recommendations for treating hypertension New trial data and guidelines have made hypertension care more
More informationHypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)
Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed
More informationHypertension JNC 8 (2014)
Hypertension JNC 8 (2014) Renewed: February 2018 Updated: February 2015 Comparison of Seventh Joint National Committee (JNC 7) vs. Eighth Joint National Committee (JNC 8) Hypertension Guidelines Methodology
More informationHYPERTENSION: UPDATE 2018
HYPERTENSION: UPDATE 2018 From the Cardiologist point of view Richard C Padgett, MD I have no disclosures HYPERTENSION ALWAYS THE ELEPHANT IN THE EXAM ROOM BUT SOMETIMES IT CHARGES HTN IN US ~78 million
More informationHYPERTENSION GUIDELINES WHERE ARE WE IN 2014
HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University
More informationHypertension Management Controversies in the Elderly Patient
Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No
More informationHypertension Update Background
Hypertension Update Background Overview Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Management Guideline Comparison
More informationHYPERTENSION: WHAT'S YOUR GOAL?
HYPERTENSION: WHAT'S YOUR GOAL? SATURDAY/3:15-4:15PM ACPE UAN: 0107-9999-17-243-L01-P 0.1 CEU/1.0 hr Activity Type: Application-Based Learning Objectives for Pharmacists: Upon completion of this CPE activity
More informationHypertension. Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute
Hypertension Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute Hypertension 2017 Classification BP Category Systolic Diastolic Normal 120 and 80 Elevated
More informationWe are delighted to have Dr. Roetzheim with us today to discuss Managing Hypertension in Older Adult Patients.
Richard Roetzheim, MD, MSPH is Professor and Chair, Department of Family Medicine at the University of South Florida Morsani College of Medicine. Dr. Roetzheim has considerable experience leading NIH funded
More informationHYPERTENSION MANAGEMENT IN ELDERLY POPULATIONS
HYPERTENSION MANAGEMENT IN ELDERLY POPULATIONS Michael J. Scalese, PharmD, BCPS, CACP Assistant Clinical Professor Auburn University Harrison School of Pharmacy July 14, 2018 DISCLOSURE/CONFLICT OF INTEREST
More informationHypertension and the SPRINT Trial: Is Lower Better
Hypertension and the SPRINT Trial: Is Lower Better 8th Annual Orange County Symposium on Cardiovascular Disease Prevention Saturday, October 8, 2016 Keith C. Norris, MD, PhD, FASN Professor of Medicine,
More informationGo low or no? Managing blood pressure in primary care. Hypertension is rarely an isolated risk factor
Cardiovascular system DEBATE Go low or no? Managing blood pressure in primary care There is much debate as to whether intensive blood pressure management, i.e. aiming for a systolic blood pressure less
More informationDISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE
ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal
More informationRecent Hypertension Guidelines
Recent Hypertension Guidelines Lawrence J. Fine, MD, DrPH, FAHA Division of Cardiovascular Sciences NHLBI/NIH February 19, 2014 Disclosures: Member of Panel Appointed to the Eighth Joint National Committee
More informationCONTRIBUTING FACTORS FOR STROKE:
CONTRIBUTING FACTORS FOR STROKE: HYPERTENSION AND HYPERCHOLESTEROLEMIA Melissa R. Stephens, MD, FAAFP Associate Professor of Clinical Sciences William Carey University College of Osteopathic Medicine LEARNING
More informationJNC 8 -Controversies. Sagren Naidoo Nephrologist CMJAH
JNC 8 -Controversies Sagren Naidoo Nephrologist CMJAH Joint National Committee (JNC) Panel appointed by the National Heart, Lung, and Blood Institute (NHLBI) First guidelines (JNC-1) published in 1977
More informationHypertension and Cardiovascular Disease
Hypertension and Cardiovascular Disease Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic,
More informationJNC-8. (Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure- 8) An Update on Hypertension Guidelines
JNC-8 (Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure- 8) An Update on Hypertension Guidelines Derrick Sorweide, DO Assistant Professor of Family Medicine,
More informationUpdate on Current Trends in Hypertension Management
Friday General Session Update on Current Trends in Hypertension Management Shawna Nesbitt, MD Associate Dean, Minority Student Affairs Associate Professor, Department of Internal Medicine Office of Student
More informationHypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic
Hypertension in 2015: SPRINT-ing ahead of JNC-8 MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic Conflits of interest? None Disclaimer The opinions contained herein are not to be considered
More informationHypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program
Hypertension: JNC-7 Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! Reference Card
More informationTreatment of Hypertension
This Clinical Resource gives subscribers additional insight related to the Recommendations published in January 2018 ~ Resource #340101 Treatment of Hypertension In 2013, the JNC 8 panel released recommendations
More informationPharmacy Updates in Primary Care. Nathan Lamberton Assistant Professor
Pharmacy Updates in Primary Care January 31 st, 2018 Nathan Lamberton Assistant Professor David N. Ombengi Associate Professor First Metformin, Then? AR is a 57 year old African American male with a PMH
More informationNew Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.
PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Disclosure No relevant
More informationOMG!! Do We Really Need All TheseAntihypertensives?? Traditional vs. Natural Therapies. Kristen Luttenberger MSN, RN, CCRN-CMC, PCCN, APN-c
OMG!! Do We Really Need All TheseAntihypertensives?? Traditional vs. Natural Therapies Kristen Luttenberger MSN, RN, CCRN-CMC, PCCN, APN-c Hypertension Defined as persistently elevated pressure in the
More information2/10/2014. Hypertension: Highlights of Hypertension Guidelines: Making the Most of Limited Evidence. Issues with contemporary guidelines
Hypertension: 214 Highlights of Hypertension Guidelines: Making the Most of Limited Evidence Michael A, Weber, MD Editor-in-Chief, The Journal of Clinical Hypertension, Professor of Medicine, Division
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Prevalence 29%; Blacks 33.5% About 72.5% treated; 53.5% uncontrolled (>140/90) Risk for poor control: Latinos, Blacks, age 18-44 and 80,
More informationEffective Date: TBD Version: 1.0 (Revised: 6/11/2014)
Protocol Title: Hypertension Effective Date: TBD Version: 1.0 (Revised: 6/11/2014) Approval By: TBD Planned Review Date: TBD 1 Purpose & Objective This protocol provides evidence-based care recommendations
More informationConsensus Core Set: Cardiovascular Measures Version 1.0
Consensus Core Set: Cardiovascular s NQF 0330 Hospital 30-day, all-cause, riskstandardized readmission rate (RSRR) following heart failure hospitalization 0229 Hospital 30-day, all-cause, riskstandardized
More informationBlood Pressure Treatment in 2018
Blood Pressure Treatment in 2018 Jay D. Geoghagan, MD, FACC Disclosures: None 1 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Advances in Management of Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Prevalence 29%; Blacks 33.5%
More informationHypertension Update Clinical Controversies Regarding Age and Race
Hypertension Update Clinical Controversies Regarding Age and Race Allison Helmer, PharmD, BCACP Assistant Clinical Professor Auburn University Harrison School of Pharmacy July 22, 2017 DISCLOSURE/CONFLICT
More informationHypertension Guidelines 2017
Hypertension Guidelines 2017 (American College of Cardiology and the American Heart Association) In 1977, the 1st comprehensive guideline for detection, evaluation, and management of high BP was published,
More informationOutcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension
Outcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension Prof. Massimo Volpe, MD, FAHA, FESC, Chair of Cardiology, Department of Clinical and Molecular Medicine
More informationTodd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM
Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between
More informationJared Moore, MD, FACP
Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner
More informationHypertension Update 2016 AREEF ISHANI, MD MS CHIEF OF MEDICINE MINNEAPOLIS VA MEDICAL CENTER PROFESSOR OF MEDICINE UNIVERSITY OF MINNESOTA
Hypertension Update 2016 AREEF ISHANI, MD MS CHIEF OF MEDICINE MINNEAPOLIS VA MEDICAL CENTER PROFESSOR OF MEDICINE UNIVERSITY OF MINNESOTA Case 1 What should be your BP goal for an elderly (> 75 yrs of
More informationLipid Management 2013 Statin Benefit Groups
Clinical Integration Steering Committee Clinical Integration Chronic Disease Management Work Group Lipid Management 2013 Statin Benefit Groups Approved by Board Chair Signature Name (Please Print) Date
More informationHypertension Management: A Moving Target
9:45 :30am Hypertension Management: A Moving Target SPEAKER Karol Watson, MD, PhD, FACC Presenter Disclosure Information The following relationships exist related to this presentation: Karol E. Watson,
More informationALLHAT. ALLHAT Antihypertensive Trial Results by Baseline Diabetic & Fasting Glucose Status
ALLHAT Antihypertensive Trial Results by Baseline Diabetic & Fasting Glucose Status 1 Introduction and Background Clinical trials have reported reduction in CV events with diuretics, CCBs, ACE inhibitors,
More information12.2. Structured, Team-Based Care Interventions for Hypertension Control
Downloaded from http://hyper.ahajournals.org/ by guest on November 13, 2017 12.2. Structured, Team-Based Care Interventions for Hypertension Control Recommendation for Structured, Team-Based Care Interventions
More informationImpact of Recent Hypertension Guidelines on Clinical Practice
C H A P T E R 144 Impact of Recent Hypertension Guidelines on Clinical Practice NK Soni, VB Jindal The movement towards evidence-based healthcare has been gaining ground quickly over the past few years,
More informationControlling Hypertension in Primary Care: Hitting a moving target?
Controlling Hypertension in Primary Care: Hitting a moving target? David J. Hyman, MD,MPH Professor of Medicine and Family & Community Medicine Chief, Section General Medicine Baylor College of Medicine
More informationScreening for Lung Cancer: U.S. Preventive Services Task Force Recommendation. Hot Off the Press and into Your Practice: The Last Year in Medical News
Hot Off the Press and into Your Practice: The Last Year in Medical News Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Moyer VA, et al. Ann Internal Med. 2014;160(5):330-338.
More informationNIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2015 August 01.
NIH Public Access Author Manuscript Published in final edited form as: JAMA Intern Med. 2014 August ; 174(8): 1397 1400. doi:10.1001/jamainternmed.2014.2492. Prevalence and Characteristics of Systolic
More information2017 ACC/AHA hypertension guidelines: Toward tighter control
COMMENTARY REBECCA BLONSKY, MD Nephrologist, Marshfield Clinic, Marshfield, WI MARC POHL, MD Consultant Staff, Department of Nephrology and Hypertension, Glickman Urological Institute, Cleveland Clinic
More informationManagement of Hypertension: JNC 8 and Beyond
Cardiovascular Innovations and Applications Vol. 1 No. 4 (2016) 409 416 ISSN 2009-8618 DOI 10.15212/CVIA.2016.0030 REVIEW Management of Hypertension: JNC 8 and Beyond Ezra A. Amsterdam, MD 1, Sandhya Venugopal,
More informationhypertension Head of prevention and control of CVD disease office Ministry of heath
hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension
More informationManagement of High Blood Pressure in Adults
Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) James, P. A. (2014, February 05). 2014 Guideline for Management
More informationHypertension Guidelines: JNC- Late, JNC- 8, or JNC- Fake?
Hypertension Guidelines: JNC- Late, JNC- 8, or JNC- Fake? Brian G. Choi, MD, MBA, FACC Associate Professor of Medicine Co-Director, Advanced Cardiac Imaging November 14, 2014 Washington, DC Disclosures
More informationHighlights of the new blood pressure and cholesterol guidelines: A whole new philosophy. Jeremy L. Johnson, PharmD, BCACP, CDE, BC-ADM
Highlights of the new blood pressure and cholesterol guidelines: A whole new philosophy Jeremy L. Johnson, PharmD, BCACP, CDE, BC-ADM OSHP 2014 Annual Meeting Oklahoma City, OK April 4, 2014 1 Objectives
More informationUpdate in Cardiology Pharmacologic Management of Cardiovascular Risk. Christopher C. Roe, MSN, ACNP
Update in Cardiology Pharmacologic Management of Cardiovascular Risk Christopher C. Roe, MSN, ACNP Objectives 1. Verbalize understanding of new pharmacologic guidelines in the treatment of hypertension
More informationHypertension Guidelines JNC Recommendations. Robert E. Bulow DO FACOI, FACC
Hypertension Guidelines JNC Recommendations Robert E. Bulow DO FACOI, FACC None Disclosures Question At what blood pressure should pharmacologic therapy be initiated in the non diabetic pt with age greater
More informationAdult Blood Pressure Clinician Guide June 2018
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Adult Blood Pressure Clinician Guide June 2018 Adult Blood Pressure Clinician Guide June 2018 Introduction This Clinician Guide is based on the 2018
More informationKDIGO Controversies Conference on Blood Pressure in CKD
KDIGO Controversies Conference on Blood Pressure in CKD September 7-10, 2017 Edinburgh, Scotland Kidney Disease: Improving Global Outcomes (KDIGO) is an international organization whose mission is to improve
More informationChallenges in Hypertension: Incorporating Evolving Clinical Data Into Practice
Challenges in Hypertension: Incorporating Evolving Clinical Data Into Practice Faculty Jan Basile, MD Professor of Medicine Seinsheimer Cardiovascular Health Program Division of General Internal Medicine
More informationDon t let the pressure get to you:
Balanced information for better care Don t let the pressure get to you: Current evidence-based goals for treating hypertension A cornerstone of primary care: Lowering high blood pressure prevents cardiovascular
More informationAdult Hypertension Clinical Practice Guidelines
NATIONAL CLINICAL PRACTICE GUIDELINES Adult Hypertension Clinical Practice Guidelines Reviewed/Approved by the National Guideline Directors: November 2016 Next Review/Approval: November 2018 Developed
More informationVA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005
VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,
More informationTarget Blood Pressure Attainment in Diabetic Hypertensive Patients: Need for more Diuretics? Waleed M. Sweileh, PhD
Target Blood Pressure Attainment in Diabetic Hypertensive Patients: Need for more Diuretics? Waleed M. Sweileh, PhD Associate Professor, Clinical Pharmacology Corresponding author Waleed M. Sweileh, PhD
More informationThe Latest Generation of Clinical
The Latest Generation of Clinical Guidelines: HTN and HLD Dave Brackett Clinical Guideline Purpose Uniform approach Awareness of key details Diagnosis Treatment Monitoring Evidence based approach Inform
More informationRenal Disease through the Ages: From Childbearing years to Old Age. Dr Elizabeth Jarvis, Renal Physician, General Physician, Obstetric Physician.
Renal Disease through the Ages: From Childbearing years to Old Age Dr Elizabeth Jarvis, Renal Physician, General Physician, Obstetric Physician. Learning Outcomes: Understand the presentation of renal
More information